Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NVO compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
NVO
Novo Nordisk A S
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
NVO
Novo Nordisk A S
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NVO
6
OMER
Omeros
supplier
LXRX
Lexicon Pharmaceuticals
supplier
COAG
Hemab Therapeutics
customer
VTVT
vTv Therapeutics
customer
2 more · NVO chain
›
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
Source: SEC EDGAR
25 more · LLY chain
›
NVO
Novo Nordisk A S
Change
40.27
▼
−0.08%
· post 40.31
Mkt cap
$180.0B
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Closed
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 6 '26
NVO
Novo Nordisk A S
vs
LLY
ELI Lilly & Co
40.27
▼
−0.08%
post 40.31
Price
1,360.90
▼
−0.28%
post 1,358.90
$180.0B
Mkt cap
$1.2T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
NVO
40.27
▼
−0.08%
vs
LLY
1,360.90
▼
−0.28%
Closed
Nov 6 '26